Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosis

Revue Neurologique

Volumn 168, Issue 11, 2012, Pages 785-794

  Bensa, C ^a   Bodiguel, E ^b,c   Brassat, D ^d   Laplaud, D ^e,f   Magy, L ^g   Ouallet, J C ^h   Zephir, H ⁱ   De Seze, J ^j,k   Blanc, F ^k,l  

^a FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c CENTRE HOSPITALIER SAINTE ANNE   (France)

^d CHU PURPAN   (France)

^e NANTES UNIVERSITY HOSPITAL   (France)

^f INSERM   (France)

^g LIMOGES UNIVERSITY HOSPITAL   (France)

^h UNIVERSITÉ DE BORDEAUX   (France)

ⁱ UNIV LILLE   (France)

^j UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^k UNIVERSITÉ DE STRASBOURG   (France)

^l Université de Strasbourg Faculté de Psychologie   (France)

more..

Author keywords

Cognitive disorders; Multiple sclerosis; Practice guideline; RAND UCLA appropriateness method; Review

Indexed keywords

AMANTADINE; AMPHETAMINE DERIVATIVE; DONEPEZIL; ERYTHROPOIETIN; MEMANTINE; METHYLPHENIDATE; MODAFINIL; PEMOLINE; PLACEBO;

ALTERNATIVE MEDICINE; ARTICLE; COGNITIVE DEFECT; COGNITIVE REHABILITATION; DISEASE COURSE; DRUG WITHDRAWAL; FATIGUE; HUMAN; MEDICAL LITERATURE; MULTIPLE SCLEROSIS; NEUROLOGIST; NEUROPSYCHOLOGICAL TEST; PATIENT CARE; PHYSICAL EXAMINATION; SYSTEMATIC REVIEW; TREATMENT PLANNING;

ALGORITHMS; COGNITION DISORDERS; CONSENSUS; HUMANS; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; PHYSICAL EXAMINATION; PRACTICE GUIDELINES AS TOPIC;

EID: 84869005067     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2012.02.009     Document Type: Article

References (70)

1. M.P. Amato, E. Portaccio, and V. Zipoli Are there protective treatments for cognitive decline in MS? J Neurol Sci 245 2006 183 186
2. M.P. Amato, E. Portaccio, B. Goretti, V. Zipoli, M. Battaglini, and M.L. Bartolozzi Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis Arch Neurol 64 2007 1157 1161
3. M.P. Amato, V. Zipoli, and E. Portaccio Cognitive changes in multiple sclerosis Expert Rev Neurother 8 2008 1585 1596
4. P.A. Arnett, S.M. Rao, L. Bernardin, J. Grafman, F.Z. Yetkin, and L. Lobeck Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis Neurology 44 3Pt1 1994 420 425
5. M.R. Basso, N. Lowery, C. Ghormley, D. Combs, and J. Johnson Self-generated learning in people with multiple sclerosis J Int Neuropsychol Soc 12 2006 640 648
6. R.H. Benedict, B. Weinstock-Guttman, I. Fishman, J. Sharma, C.W. Tjoa, and R. Bakshi Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden Arch Neurol 61 2004 226 230
7. R.H. Benedict, J.M. Bruce, M.G. Dwyer, N. Abdelrahman, S. Hussein, and B. Weinstock-Guttman Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis Arch Neurol 63 2006 1301 1306
8. R.H. Benedict, F. Munschauer, P. Zarevics, D. Erlanger, V. Rowe, and T. Feaster Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients J Neurol 255 2008 848 852
9. A. Brenk, K. Laun, and C.G. Haase Short-term cognitive training improves mental efficiency and mood in patients with multiple sclerosis Eur Neurol 60 2008 304 309
10. H. Brissart, M. Sauvée, C. Latarche, C. Dillier, and M. Debouverie Integration of cognitive impairment in the expanded disability status scale of 215 patients with multiple sclerosis Eur Neurol 64 2010 345 350
11. M. Calabrese, F. Agosta, F. Rinaldi, I. Mattisi, P. Grossi, and A. Favaretto Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis Arch Neurol 66 2009 1144 1150
12. M. Calabrese, F. Rinaldi, I. Mattisi, P. Grossi, A. Favaretto, and M. Atzori Widespread cortical thinning characterizes patients with MS with mild cognitive impairment Neurology 74 2010 321 328
13. N. Carney, R.M. Chesnut, H. Maynard, N.C. Mann, P. Patterson, and M. Helfand Effect of cognitive rehabilitation on outcomes for persons with traumatic brain injury: a systematic review J Head Trauma Rehabil 14 1999 277 307
14. C. Christodoulou, W.S. MacAllister, N.A. McLinskey, and L.B. Krupp Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option? CNS Drugs 22 2008 87 97
15. K.D. Cicerone, C. Dahlberg, K. Kalmar, D.M. Langenbahn, J.F. Malec, and T.F. Bergquist Evidence-based cognitive rehabilitation: recommendations for clinical practice Arch Phys Med Rehabil 81 2000 1596 1615
16. B.A. Cohen Identification, causation, alleviation, and prevention of complications (ICAP): an approach to symptom and disability management in multiple sclerosis Neurology 71 24 Suppl. 3 2008 S14 S20
17. G. Comi, M. Rovaris, L. Leocani, V. Martinelli, and M. Filippi Assessment of the damage of the cerebral hemispheres in MS using neuroimaging techniques J Neurol Sci 172 Suppl. 1 2000 S63 S66
18. H.J. Crayton, and H.S. Rossman Managing the symptoms of multiple sclerosis: a multimodal approach Clin Ther 28 2006 445 460
19. G.L. Defer, F. Daniel, and N. Derache Therapeutic management of cognitive impairments in multiple sclerosis Rev Neurol (Paris) 163 2007 703 710
20. M.S. Deloire, E. Salort, M. Bonnet, Y. Arimone, M. Boudineau, and H. Amieva Cognitive impairment as marker of diffuse brain abnormalities in early relapsing-remitting multiple sclerosis J Neurol Neurosurg Psychiatry 76 2005 519 526
21. M. Deloire, A. Ruet, D. Hamel, and M. Bonnet Early cognitive impairment in multiple sclerosis predicts disability outcome several years later Mult Scler 16 2010 581 587
22. M.S. Deloire, A. Ruet, D. Hamel, M. Bonnet, V. Dousset, and B. Brochet MRI predictors of cognitive outcome in early multiple sclerosis Neurology 76 2011 1161 1167
23. J.C. Ebers PRISMS (Prevention of Relapses and Disability by Interferon β-1a Subcutaneously in Multiple Sclerosis) study group. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis Lancet 352 1998 1498 1504
24. H. Ehrenreich, B. Fischer, C. Norra, F. Schellenberger, N. Stender, and M. Stiefel Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis Brain 130 2007 2577 2588
25. Fédération française de neurologie (FFN) Agence nationale d'accréditation et d'évaluation en santé (ANAES). La sclérose en plaques. Conférence de consensus Rev Neurol (Paris) 157 2001 904 1192
26. B.I. Glanz, C.M. Holland, S.A. Gauthier, E.L. Amunwa, Z. Liptak, and M.K. Houtchens Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis Mult Scler 13 2007 1004 1110
27. Y. Goverover, N. Chiaravalloti, and J. DeLuca Self-generation to improve learning and memory of functional activities in persons with multiple sclerosis: meal preparation and managing finances Arch Phys Med Rehabil 89 2008 1514 1521
28. Y. Harel, N. Appleboim, M. Lavie, and A. Achiron Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process J Neurol Sci 276 2009 38 40
29. Haute Autorité de santé française Bases méthodologiques pour l'élaboration de recommandations professionnelles par consensus formalisé 2006 http://www.has-sante.fr
30. Haute Autorité de santé française Méthode et processus d'adaptation des recommandations pour la pratique clinique existantes 2007 http://www.has-sante.fr
31. T. Henze, P. Rieckmann, and K.V. Toyka Multiple sclerosis therapy consensus group of the German multiple sclerosis society. Symptomatic treatment of multiple sclerosis Eur Neurol 56 2006 78 105
32. M.K. Houtchens, R.H. Benedict, R. Killiany, J. Sharma, Z. Jaisani, and B. Singh Thalamic atrophy and cognition in multiple sclerosis Neurology 69 2007 1213 1223
33. L.D. Jacobs, D.L. Cookfair, R.A. Rudick, R.M. Herndon, J.R. Richert, and A.M. Salazar Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis Ann Neurol 39 1996 285 294
34. K.P. Johnson, B.R. Brooks, J.A. Cohen, C.C. Ford, J. Goldstein, and R.P. Lisak Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis. Results of a phase III multicenter, double-blind, placebo-controlled trial Neurology 45 1995 1268 1276
35. M. Khalil, C. Enzinger, C. Langkammer, K. Petrovic, M. Loitfelder, and M. Tscherner Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome Mult Scler 17 2011 173 180
36. L.B. Krupp, C. Christodoulou, P. Melville, W.F. Scherl, W.S. MacAllister, and L.E. Elkins Donepezil improved memory in multiple sclerosis in a randomized clinical trial Neurology 63 2004 1579 1585
37. L.B. Krupp, C. Christodoulou, P. Melville, W.F. Scherl, L. Pai, and L.R. Muenz Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis Neurology 76 2011 1500 1507
38. R.H. Lazeron, J.B. Boringa, M. Schouten, B.M. Uitdehaag, E. Bergers, and J. Lindeboom Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis Mult Scler 11 2005 524 531
39. J. Lengenfelder, N.D. Chiaravalloti, and J. DeLuca The efficacy of the generation effect to improve new learning in persons with traumatic brain injury Rehabil Psychol 17 2007 273 292
40. E. Lensch, M. Matzke, H.F. Petereit, P. Scherer, S. Schramm, and P. Calabrese Identification and management of cognitive impairments in multiple sclerosis - a consensus approach J Neurol 253 Suppl. 1 2006 I29 I31
41. J.F. Lovera, E. Frohman, T.R. Brown, D. Bandari, L. Nguyen, and V. Yadav Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial Mult Scler 16 2010 715 723
42. S.A. Morrow, T. Kaushik, P. Zarevics, D. Erlanger, M.F. Bear, and F.E. Munschauer The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial J Neurol 256 2009 1095 1102
43. F. Nelson, S. Datta, N. Garcia, N.L. Rozario, F. Perez, and G. Cutter Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis Mult Scler 179 2011 1122 1129
44. NIH consensus development panel on rehabilitation of persons with traumatic brain injury Consensus conference rehabilitation of persons with traumatic brain injury JAMA 282 1999 974 983
45. A. O'Brien, N. Chiaravalloti, J.C. Arango-Lasprilla, J. Lengenfelder, and J. DeLuca An investigation of the differential effect of self-generation to improve learning and memory in multiple sclerosis and traumatic brain injury Neuropsychol Rehabil 17 2007 273 292
46. A.R. O'Brien, N. Chiaravalloti, Y. Goverover, and J. Deluca Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature Arch Phys Med Rehabil 89 2008 761 769
47. Ouallet JC, Bodiguel E, Bensa C, Blanc F, Brassat D, Laplaud D, et al. Recommendations for useful serum testing with suspected multiple sclerosis. Rev Neurol (Paris): accepted for publication (in press), online since feb 2012.
48. F. Patti Cognitive impairment in multiple sclerosis Mult Scler 15 2009 2 8
49. S.H. Pierson, and N. Griffith Treatment of cognitive impairment in multiple sclerosis Behav Neurol 17 2006 53 67
50. J. Porcel, and X. Montalban Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis J Neurol Sci 245 2006 177 181
51. S.M. Rao, G.J. Leo, V.M. Haughton, P. St Aubin-Faubert, and L. Bernardin Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis Neurology 39 2Pt1 1989 161 166
52. S.D. Roosendaal, B. Moraal, P.J. Pouwels, H. Vrenken, J.A. Castelijns, and F. Barkhof Accumulation of cortical lesions in MS: relation with cognitive impairment Mult Scler 15 2009 708 714
53. E.M. Rosti-Otajärvi, and P.I. Hämäläinen Neuropsychological rehabilitation for multiple sclerosis Cochrane Database Syst Rev 11 2011 CD009131
54. M. Rovaris, M. Filippi, M. Falautano, L. Minicucci, M.A. Rocca, and V. Martinelli Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis Neurology 50 1998 1601 1608
55. V. Shaygannejad, M. Janghorbani, F. Ashtari, H.A. Zanjani, and N. Zakizade Effects of rivastigmine on memory and cognition in multiple sclerosis Can J Neurol Sci 35 2008 476 481
56. L. Shinto, C. Calabrese, C. Morris, V. Yadav, D. Griffith, and R. Frank A randomized pilot study of naturopathic medicine in multiple sclerosis J Altern Complement Med 14 2008 489 496 [Erratum in: J Altern Complement Med 2008;14:793]
57. M. Summers, L. Fisniku, V. Anderson, D. Miller, L. Cipolotti, and M. Ron Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier Mult Scler 14 2008 197 204
58. J.F. Sumowski, N. Chiaravalloti, D. Erlanger, T. Kaushik, R.H. Benedict, and J. DeLuca l-amphetamine improves memory in MS patients with objective memory impairment Mult Scler 17 2011 1141 1145
59. T. Swirsky-Sacchetti, D.R. Mitchell, J. Seward, C. Gonzales, F. Lublin, and R. Knobler Neuropsychological and structural brain lesions in multiple sclerosis: a regional analysis Neurology 42 1992 1291 1295
60. N. Tesar, K. Bandion, and U. Baumhackl Efficacy of a neuropsychological training programme for patients with multiple sclerosis - a randomised controlled trial Wien Klin Wochenschr 117 2005 747 754
61. The IFNB multiple sclerosis study group Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial Neurology 43 1993 655 661
62. P.W. Thomas, S. Thomas, C. Hillier, K. Galvin, and R. Baker Psychological interventions for multiple sclerosis Cochrane Database Syst Rev 1 2006 CD004431
63. A.J. Thompson Neurorehabilitation in multiple sclerosis: foundations, facts and fiction Curr Opin Neurol 18 2005 267 271
64. L. Tiemann, I.K. Penner, M. Haupts, U. Schlegel, and P. Calabrese Cognitive decline in multiple sclerosis: impact of topographic lesion distribution on differential cognitive deficit patterns Mult Scler 15 2009 1164 1174
65. H. Tumani, and I. Uttner Influences on cognition by immunosuppression and immunomodulation in multiple sclerosis J Neurol 254 Suppl. 2 2007 II69 II72 [Erratum in: J Neurol 2008;255:309-10]
66. P. Villoslada, G. Arrondo, J. Sepulcre, M. Alegre, and J. Artieda Memantine induces reversible neurologic impairment in patients with MS Neurology 72 2009 1630 1633
67. A. Winkelmann, C. Engel, A. Apel, and U.K. Zettl Cognitive impairment in multiple sclerosis J Neurol 254 Suppl. 2 2007 II35 II42
68. H. Zéphir, J. de Seze, K. Dujardin, G. Dubois, M. Cabaret, and S. Bouillaguet One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis Mult Scler 11 2005 360 363
69. H. Zéphir, J. de Sèze, K. Dujardin, G. Dubois, M. Cabaret, and S. Bouillaguet Cognitive impact of mitoxantrone and methylprednisolone in multiple sclerosis: an open-label study Rev Neurol (Paris) 164 2008 47 52
70. V. Zipoli, B. Goretti, B. Hakiki, G. Siracusa, S. Sorbi, and E. Portaccio Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes Mult Scler 16 2010 62 67